U.S. Construction Stock News

National Health Investors (NHI) closed out FY 2025 with Q4 revenue of US$107.5 million and basic EPS of US$0.80, alongside funds from operations of US$58.5 million, which is a key earnings measure for healthcare REIT investors. The company reported quarterly revenue of US$85.8 million in Q4 2024 and US$107.5 million in Q4 2025, while basic EPS moved from US$0.96 to US$0.80 over the same period, providing a view of how the top line and earnings per share have developed into the latest release...

Carpenter Technology (NYSE:CRS) announced that Brian Malloy will become Chief Executive Officer, succeeding Tony Thene. Thene will transition to the role of Executive Chairman, reshaping the company’s senior leadership structure. The leadership changes signal a new phase of direction for Carpenter Technology and are material for shareholders and customers. Carpenter Technology, a producer of specialty alloys and materials, sits at the intersection of aerospace, defense, medical and other...

If you are wondering whether Philip Morris International (NYSE: PM) still offers value at around US$186.83 a share, you are not alone. This article is built to help you make sense of that question. The stock has returned 1.9% over the past week, 4.6% over the past month, 16.6% year to date and 24.6% over the past year, with a very large 3 year return and a very large 5 year return that many investors are trying to put into context. Recent headlines around Philip Morris International have...

Recent pressure on Robert Half (RHI) shares has been tied to an analyst downgrade following a US$17 million cost action charge and fresh global tariff announcements, both contributing to near term questions around profitability and demand. See our latest analysis for Robert Half. The recent analyst downgrade, tariff headlines and the US$17 million cost action charge have come on top of weaker share price momentum. The 30 day share price return of 9.39% and year to date share price return of...

Fresh off its Q2 2026 print, Zscaler (ZS) reported revenue of US$815.8 million and a basic EPS loss of US$0.21, with net income excluding extra items at a loss of US$34.3 million, setting the tone for how investors will read the quarter. The company has seen revenue move from US$647.9 million in Q2 2025 through to US$815.8 million in Q2 2026, while quarterly basic EPS over that stretch has ranged from a loss of US$0.05 in Q2 2025 to a loss of US$0.21 in the latest quarter. As a result, the...

Zimmer Biomet Holdings recently showcased new clinical and operational data alongside its “Magnificent Seven” orthopedic innovations, including advanced robotics, AI-driven navigation, and the Persona IQ smart knee implant, at the AAOS 2026 Annual Meeting. An interesting angle for investors is how Zimmer Biomet is pairing traditional implant franchises like the Oxford Cementless Partial Knee with emerging smart and robotic systems to deepen its integrated orthopedic ecosystem. We’ll now...

FirstSun Capital Bancorp (NasdaqGS:FSUN) has received Office of the Comptroller of the Currency approval for its planned merger with First Foundation Inc. The merger remains subject to Federal Reserve approval and shareholder votes from both companies. If completed, the transaction is expected to significantly expand the combined bank's operations and product platform. FirstSun Capital Bancorp, a regional banking platform focused on commercial and consumer clients, is moving through a key...

Nutanix (NasdaqGS:NTNX) and AMD announced a multi year partnership to co develop open, full stack AI infrastructure platforms for enterprises. AMD plans to invest US$150 million in Nutanix and provide up to US$100 million for joint research and development. The collaboration focuses on production ready AI platforms tailored to varied enterprise workloads, including agentic AI and cloud infrastructure use cases. Nutanix, known for its software centric cloud infrastructure platform, is...

Stride (NYSE:LRN) is dealing with operational disruption after a failed platform upgrade that has affected student enrollment and withdrawal rates. The enrollment issues have coincided with some institutional investors, including Polen 5Perspectives Small Growth Strategy, exiting their positions. The situation raises questions about the stability of Stride’s core platform and how quickly management can restore normal operations. For investors watching NYSE:LRN, the current share price of...

If you are wondering whether Nasdaq’s current share price lines up with its underlying worth, you are not alone. This article is built to help you weigh what you are really paying for. Nasdaq closed at US$87.58 recently, with returns of 7.0% over the past week, an 11.3% decline over the last 30 days, a 9.4% decline year to date, but gains of 7.1% over 1 year, 62.6% over 3 years and 94.4% over 5 years. Recent headlines around Nasdaq have focused on its role as a major market operator and...

Schrödinger, Inc. reported full-year 2025 results, with sales of US$56.37 million and total revenue of US$255.87 million, while reducing its net loss to US$103.27 million and basic loss per share from continuing operations to US$1.41. The combination of strong revenue growth and a substantially smaller loss suggests the company is scaling its platform while exercising tighter cost control. We’ll now examine how this sharp revenue increase and narrower loss shape Schrödinger’s existing...

IPG Photonics (NasdaqGS:IPGP) has received an adverse ruling from the Unified Patent Court in Germany in a patent infringement case with Trumpf SE & Co. KG involving adjustable mode beam lasers. The decision may lead to an injunction, product recall, or damages affecting certain products in key European markets. In parallel, the company announced a substantial follow on order from Lockheed Martin for its CROSSBOW counter UAS laser systems. At a share price of $131.57, IPG Photonics comes...

If you are wondering whether Sociedad Química y Minera de Chile shares are still offering value at current levels, this article is here to unpack what the current price might be implying about the business. The stock last closed at US$76.30, with a 6.2% return over the past 7 days, a 9.4% return year to date, a 98.9% return over 1 year, a 71.6% return over 5 years and an 8.7% decline over 30 days. This can naturally raise questions about where expectations and risks now sit. Recent headlines...

Western Midstream Partners (WES) is back in focus after its fourth quarter 2025 results missed earnings and revenue forecasts, even as management paired the release with record full-year adjusted EBITDA and higher 2026 distribution guidance. See our latest analysis for Western Midstream Partners. At a share price of $41.59, Western Midstream Partners has seen steady momentum, with a 90 day share price return of 5.75% and a 1 year total shareholder return of 12.53%, building on a very large 5...

Graphic Packaging Holding (GPK) has quickly come into focus after amending its credit agreement to allow higher leverage, while also facing legal investigations linked to projected 2026 Adjusted EBITDA pressure and prior share price weakness. See our latest analysis for Graphic Packaging Holding. The leverage covenant change, legal investigations, and recent dividend declaration all come against a backdrop of weaker share price momentum, with a 30 day share price return of 17.59% and a 1 year...

PepsiCo (NasdaqGS:PEP) is rolling out viral prebiotic soda brand Poppi in the UK, marking the drink’s first major move outside the U.S. The company is expanding its functional beverage range with a new Pepsi Prebiotic Cola, now available across the U.S. market. PepsiCo is teaming up with Jack Link’s on Doritos flavored jerky and tying Bubly to the Super Mario Galaxy Movie through themed drinks and interactive giveaways. For investors watching NasdaqGS:PEP, these launches and partnerships...

Why Genworth Financial Is On Investors’ Radar Today Genworth Financial (GNW) is back in focus after recent trading left the stock modestly lower over the week but slightly higher over the past month, prompting investors to reassess its insurance driven business mix and valuation. See our latest analysis for Genworth Financial. At a share price of US$8.44, Genworth’s recent 1 day share price decline of 2.43% and 7 day share price return of 3.87% contrast with a 1 year total shareholder return...

What recent returns tell you about Arch Capital Group (ACGL) Arch Capital Group (ACGL) has drawn fresh attention after a steady run, with the stock showing gains over the past week, month, past 3 months, year to date, and the past year. Over longer stretches, its reported 3 year and 5 year total returns are also positive, which helps frame the current share price of $100.15 that investors are reacting to today. See our latest analysis for Arch Capital Group. For context, Arch Capital Group’s...

If you are wondering whether Parker-Hannifin's current share price still offers value, this article walks through what the numbers are saying about the stock today. The shares recently closed at US$1,009.18, with returns of 10.1% over the last 30 days, 12.9% year to date, and 52.4% over 1 year, while the 3 year and 5 year returns sit at 190.3% and 259.2% respectively. This follows a 1.3% decline over the past week. Recent coverage has focused on Parker-Hannifin as a large US capital goods...

CarMax, NYSE:KMX, has launched a vehicle shopping app in the ChatGPT app store, positioning itself as the first U.S. auto retailer to offer a dedicated conversational AI car buying and selling experience. The new app allows users to search, compare, and explore CarMax’s nationwide inventory using natural language directly within ChatGPT. The move is aimed at aligning the car buying process with changing consumer habits around digital and AI assisted shopping. CarMax enters this launch with...

Earlier this week, Fannie Mae launched fixed-price cash tender offers to repurchase a wide range of Connecticut Avenue Securities notes, totaling more than US$1.20 billion in original principal, with prices above par set out in a detailed Offer to Purchase. Alongside these tenders, the company is operating against a backdrop of directed government support for its bond market, highlighting how policy and liability management can jointly shape its balance sheet and funding profile. We’ll now...

If you are wondering whether Cardinal Health's share price still reflects fair value after its strong run, you are not alone. This article will walk through what the current numbers might be telling you. The stock last closed at US$229.23, with returns of 2.1% over 7 days, 9.0% over 30 days, 11.4% year to date, 79.3% over 1 year and 221.6% over 3 years. This naturally raises questions about how much of the story is already priced in. Recent news flow around Cardinal Health has focused on its...

Why Triumph Financial is on investors’ radar today Triumph Financial (TFIN) has drawn fresh attention after a period where the stock logged a 10.4% decline over the past week and a 11.8% drop over the past month. Those short term moves come against a mixed backdrop of returns over longer horizons. This creates a natural pause point for investors assessing how the bank’s current US$55.86 share price lines up with its recent financial results. See our latest analysis for Triumph...

Supernus Pharmaceuticals reported record revenues in 2025. The company completed the integration of Sage Therapeutics. New products ONAPGO for Parkinson's disease and ZURZUVAE for postpartum depression were launched. The business expanded into new therapeutic areas despite supply constraints. For investors looking at NasdaqGM:SUPN, these company updates come with a stock that last closed at $54.73 and has returned 70.7% over the past year. Over 3 years the stock is up 37.5%, and over 5...